vcfirmsdirectory.com

Venture capital · Early stage

Invivo Partners

Barcelona-based venture firm investing in early-stage biotech and AI-driven deeptech companies, mainly European with an emphasis on Spain, run by three founding partners and backed by public and private investors.

BarcelonaRegistered · Barcelona
New investments · 12 months
Fund vehiclesPublic
5
5 active · AIF · EuVECA
First chequePublic
€2M–€4M
From the firm’s website
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 23 Oct 2026, 01:34 CESTSources: ESMA register · invivo.partners

Investment activity

Round-by-round activity is part of PRO

See every round Invivo Partners joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Invivo Partners right for your round?

Is Invivo Partners a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
5
5 active · AIF · EuVECA
ESMA register
On the register sincePublic
2023
22 Sep 2023
ESMA register of EuVECA managers
First chequePublic
€2M–€4M
From the firm’s website
invivo.partners
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (ESMA register).

INVIVO VENTURES III PARALLEL FUND, FCRE, S.A.AIF · Active · Spain
INVIVO VENTURES III PARALLEL FUND, FCRE, S.A.EuVECA · Active · Spain
INVIVO VENTURES III, FCREEuVECA · Active · Spain
INVIVO VENTURES III, FCREAIF · Active · Spain
INVIVO VENTURES, FCRAIF · Active · Spain
Deployed (new cheques)
Next fund expected

Latest investments

Rounds Invivo Partners joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round Invivo Partners joined

Round sizes, Invivo Partners’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

Minoryx TherapeuticsSanifit TherapeuticsnLife TherapeuticsPeptomycVersantisGlyCardial DiagnosticsARTHEx BiotechPulmobioticsGyala TherapeuticsTelum Therapeuticsand 8 more

Portfolio and exits

Every company Invivo Partners backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Invivo Partners puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Invivo Partners

Events where Invivo Partners’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Invivo Partners’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

8 Sep 2025New deal
14 Oct 2024New deal
22 Sep 2023RegisterINVIVO PARTNERS, SGEIC, S.A. registered as a EuVECA manager.ESMA register · public record

Founders also look at

Frequently asked questions

Invivo Partners is based in Barcelona, Spain. Its registered address is PASEO DE GRACIA 54, 2º D BARCELONA BARCELONA 08007.

5 fund vehicles are on public registers (ESMA register), including INVIVO VENTURES III PARALLEL FUND, FCRE, S.A., INVIVO VENTURES III PARALLEL FUND, FCRE, S.A. and INVIVO VENTURES III, FCRE.

Stages: Pre-seed, Seed, Series A. Sectors: Biotech, Life sciences, AI, Deep tech and hardware, Robotics, Space, Mobility, Climate and energy. From the firm’s own website.

Seeks biotech with convincing animal-model evidence and first-in-class potential, plus AI-driven deeptech aimed at real problems, mostly in healthcare. Wants disruptive platforms, a clear roadmap and budget, committed multidisciplinary teams, room to extend into related applications and strong IP barriers. Enters at pre-seed, seed or Series A and adds follow-on capital as milestones are reached. From the firm’s own website.

€2M to €4M per investment, according to the firm’s own website.

Invivo Partners lists 18 portfolio companies on its website, including Minoryx Therapeutics, Sanifit Therapeutics, nLife Therapeutics, Peptomyc and Versantis.

Firms whose websites list some of the same companies include Columbus Venture Partners, AdBio and AMR Action Fund.

Know before Invivo Partners’s next round is announced.

PRO tracks Invivo Partners’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Invivo PartnersGet Invivo Partners’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.